Sponsor
Weill Medical College of Cornell University
Status
Terminated
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT04547985
This is a study to see how effective oral naltrexone is as treatment for prolonged grief disorder (PGD). Participants will take their assigned medication for 8 weeks, with monthly visits to assess symptom severity, social connectedness, and adverse reactions.
Intervention
Naltrexone HCl 50 MG Oral Tablet, Placebo
Condition
Prolonged Grief Disorder
Investigators
Holly G Prigerson, PhD